Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

Delayed Data
As of Aug 22
 +1.12 / +1.32%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 19 analysts offering 12-month price forecasts for Alnylam Pharmaceuticals Inc have a median target of 90.00, with a high estimate of 126.00 and a low estimate of 50.00. The median estimate represents a +4.90% increase from the last price of 85.80.

Analyst Recommendations

The current consensus among 20 polled investment analysts is to Hold stock in Alnylam Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.38%
Growthannually -9.60%


Growthquarterly 51.47%
Growthannually 64.07%
Key to the earnings and sales forecast charts.